| Document Date: 2012-05-15 04:50:24
Open Document File Size: 442,12 KBShare Result on Facebook
City New Hope / / Company Amerilab Technologies / CSC Publishing / / Continent Europe / / Country United States / / Event Product Issues / / Facility Al-Azhar University / University of Wisconsin-Madison / / / IndustryTerm unacceptable product / pharmaceutical and nutraceutical / pharmaceutical and dietary industries / conventional blending equipment / effervescent product / clear solution / chemical assays / non-polar carbon dioxide gas molecules / pharmaceuticals / water-active solution / effervescent products / excessive gas / contract manufacturer / chosen blending equipment / marketable product / chemical reaction / active pharmaceutical ingredients / binder solution / / MedicalCondition constipation / MS / / MedicalTreatment antibiotics / / Organization Al-Azhar University / National Science Foundation / FDA / University of Wisconsin / / Person Robert E. Lee / / / Position research and development senior scientist / contractor / / Product diflunisal / Capsules Active ingredients Effervescent tablets / amoxicillin / disulfiram / Effervescent tablets / polyethylene glycol / sodium bicarbonate / dextrose / sorbitol / packaging materials / / ProvinceOrState Wisconsin / Minnesota / / Technology carbonation / Conclusion Effervescent technology / / URL www.amerilabtech.com / /
SocialTag |
Key facts about a unique, effective dosage form Effervescence has proved its utility as an oral delivery system in the pharmaceutical and dietary industries for decades. In Europe, effervescent dosage forms are widesprea